If you're getting yeast infections four or more times a year, you may have recurrent vulvovaginal candidiasis (RVVC) — a clinical category that requires a different treatment approach than the standard single-dose fluconazole. CodyMD can treat acute episodes; chronic management of RVVC benefits from in-person GYN evaluation and a longer regimen. Here's what the guidelines actually recommend.

What counts as recurrent

Per the CDC STI Treatment Guidelines, recurrent vulvovaginal candidiasis is defined as 4 or more symptomatic episodes per year. It affects roughly 5–8% of women at some point. The episodes are real, documented yeast infections — not a single prolonged infection or recurring misdiagnosis.

Why recurrent yeast happens

Several factors increase recurrence risk: poorly controlled diabetes (high blood sugar feeds Candida); immunocompromise (HIV, chemotherapy, chronic steroids); frequent antibiotic use (disrupts protective vaginal Lactobacillus); hormonal factors (estrogen-containing contraceptives, pregnancy); behavioral factors (douching, scented products); and — importantly — non-albicans Candida species (especially Candida glabrata) that are often resistant to standard fluconazole. The ACOG vaginitis guidance explicitly recommends fungal culture for recurrent cases to identify resistant species.

Treatment for recurrent yeast

Induction phase: three doses of fluconazole 150mg, taken 72 hours apart (day 1, day 4, day 7). This clears the active infection more reliably than a single dose for recurrent cases.

Maintenance phase: fluconazole 150mg once weekly for 6 months. This reduces recurrence by 50–70% during the maintenance period per CDC data, though many patients have recurrence again after stopping.

Topical alternatives: 10–14 day topical azole therapy for induction; clotrimazole vaginal suppository weekly for maintenance.

Non-albicans species: when culture confirms resistance, options include boric acid 600mg vaginal capsules nightly for 14 days, nystatin, or topical flucytosine — these are specialty regimens best managed by GYN.

Why GYN evaluation matters for recurrent cases

Recurrent yeast deserves a workup, not just repeat prescriptions. An OB-GYN can: confirm the diagnosis with culture; identify the specific Candida species; screen for diabetes, immunocompromise, and other risk factors; review medications that may contribute; and personalize the maintenance regimen. The 6-month maintenance protocol is also something most patients want monitored — weekly dosing for half a year is a meaningful clinical commitment.

What CodyMD can vs can't do for recurrent yeast

Acute episode within a known recurrent pattern: CodyMD can prescribe single-dose or the induction-phase 3-dose fluconazole if your symptoms fit classic yeast and you have a confirmed prior diagnosis. The licensed physician will make this call case-by-case.

Maintenance/prevention regimen: not a CodyMD service. The 6-month weekly fluconazole protocol needs in-person GYN follow-up to monitor, evaluate underlying causes, and adjust if needed.

Diagnostic workup: fungal culture, glucose screening, and underlying-cause evaluation require in-person care or referral.

When to start with GYN, not CodyMD

If you've had multiple yeast episodes recently, the more useful next step is an OB-GYN visit — not a fourth single-dose prescription. CodyMD is best suited for the occasional uncomplicated episode. For symptoms that may not be yeast, see yeast vs BV vs trich. For what fluconazole does, see fluconazole explained, and for the doctors making the call, see licensed CodyMD doctors.

Bottom line

Recurring yeast infections deserve a workup, not just repeat single-dose prescriptions. CodyMD handles occasional acute episodes; chronic recurrence belongs with an in-person OB-GYN who can identify underlying causes and personalize a maintenance regimen.